Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 1
1987 2
1988 7
1989 1
1990 1
1991 11
1992 6
1993 12
1994 5
1995 8
1996 6
1997 9
1998 6
1999 5
2000 5
2001 5
2002 8
2003 10
2004 6
2005 11
2006 5
2007 7
2008 10
2009 5
2010 6
2011 6
2012 10
2013 5
2014 7
2015 9
2016 10
2017 10
2018 20
2019 6
2020 9
2021 10
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

251results
Results by year
Filters applied:.Clear all
Page 1
Perspectives for systems biology in the management of tuberculosis.
Kontsevaya I, Lange C, Comella-Del-Barrio P, Coarfa C, DiNardo AR,Gillespie SH, Hauptmann M, Leschczyk C, Mandalakas AM, Martinecz A, Merker M, Niemann S, Reimann M, Rzhepishevska O, Schaible UE, Scheu KM, Schurr E, Abel Zur Wiesch P, Heyckendorf J. Kontsevaya I, et al. Among authors:gillespie sh. Eur Respir Rev. 2021 May 25;30(160):200377. doi: 10.1183/16000617.0377-2020. Print 2021 Jun 30. Eur Respir Rev. 2021. PMID:34039674 Free article. Review.
Perspective for Precision Medicine for Tuberculosis.
Lange C, Aarnoutse R, Chesov D, van Crevel R,Gillespie SH, Grobbel HP, Kalsdorf B, Kontsevaya I, van Laarhoven A, Nishiguchi T, Mandalakas A, Merker M, Niemann S, Köhler N, Heyckendorf J, Reimann M, Ruhwald M, Sanchez-Carballo P, Schwudke D, Waldow F, DiNardo AR. Lange C, et al. Among authors:gillespie sh. Front Immunol. 2020 Oct 8;11:566608. doi: 10.3389/fimmu.2020.566608. eCollection 2020. Front Immunol. 2020. PMID:33117351 Free PMC article. Review.
Human toxocariasis.
Gillespie SH. Gillespie SH. J Appl Bacteriol. 1987 Dec;63(6):473-9. doi: 10.1111/j.1365-2672.1987.tb02716.x. J Appl Bacteriol. 1987. PMID:3326868 Review. No abstract available.
Mycobacterial Load Assay.
Gillespie SH, Sabiiti W, Oravcova K. Gillespie SH, et al. Methods Mol Biol. 2017;1616:89-105. doi: 10.1007/978-1-4939-7037-7_5. Methods Mol Biol. 2017. PMID:28600763
Defining dormancy in mycobacterial disease.
Lipworth S, Hammond RJH, Baron VO, Hu Y, Coates A,Gillespie SH. Lipworth S, et al. Among authors:gillespie sh. Tuberculosis (Edinb). 2016 Jul;99:131-142. doi: 10.1016/j.tube.2016.05.006. Epub 2016 May 28. Tuberculosis (Edinb). 2016. PMID:27450015 Review.
The role of moxifloxacin in tuberculosis therapy.
Gillespie SH. Gillespie SH. Eur Respir Rev. 2016 Mar;25(139):19-28. doi: 10.1183/16000617.0085-2015. Eur Respir Rev. 2016. PMID:26929417 Free article. Review.
Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg-1利福平。
Te Brake LHM, de Jager V, Narunsky K, Vanker N, Svensson EM, Phillips PPJ,Gillespie SH, Heinrich N, Hoelscher M, Dawson R, Diacon AH, Aarnoutse RE, Boeree MJ; PanACEA Consortium. Te Brake LHM, et al. Among authors:gillespie sh. Eur Respir J. 2021 Jul 8;58(1):2000955. doi: 10.1183/13993003.00955-2020. Print 2021 Jul. Eur Respir J. 2021. PMID:33542056 Free PMC article.
Moxifloxacin for tuberculosis.
Singh KP, Brown M, Murphy ME,Gillespie SH. Singh KP, et al. Among authors:gillespie sh. Lancet Infect Dis. 2012 Mar;12(3):176; author reply 177-8. doi: 10.1016/S1473-3099(11)70350-4. Lancet Infect Dis. 2012. PMID:22361420 No abstract available.
Pathogenesis of pneumococcal infection.
Gillespie SH, Balakrishnan I. Gillespie SH, et al. J Med Microbiol. 2000 Dec;49(12):1057-1067. doi: 10.1099/0022-1317-49-12-1057. J Med Microbiol. 2000. PMID:11129716 Review.
A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA).
Sabiiti W, Mtafya B,老林a DA, Dombay E, Baron VO, Azam K, Oravcova K, Sloan DJ,Gillespie SH. Sabiiti W, et al. Among authors:gillespie sh. J Vis Exp. 2020 Apr 30;(158). doi: 10.3791/60460. J Vis Exp. 2020. PMID:32420999
251results